No description available.

No description available.

No description available.

No description available.

Neutrophil extracellular traps (NETs) are a link between infection and coagulation in sepsis. The major structural component of NETs is nucleosomes, consisting of DNA and histones. NETs not only act as a scaffold to trap platelets, but NET components also promote coagulation and impair fibrinolysis. Thus, removal of extracellular DNA by DNases may be a potential therapeutic strategy for sepsis. Since heparin is used for thromboprophylaxis in sepsis and may also be a potential anti-sepsis therapy, we investigated the mechanisms by which various forms of heparins modulate DNase function. There are two types of DNases in vivo: DNase I (produced by exocrine and endocrine glands) and DNase1L3 (secreted by immune cells). DNase I cleaves free DNA, whereas DNase1L3 preferentially cleaves DNA in complex with proteins such as histones. In this study, we investigated how DNase I and DNase1L3 activities are modulated by the following heparins: unfractionated heparin (UFH), enoxaparin (a low-molecular-weight heparin), Vasoflux (a low-molecular-weight, non-anticoagulant heparin), and fondaparinux (the pentasaccharide unit). Using agarose gel experiments, we showed that UFH, enoxaparin, and Vasoflux enhance the ability of DNase I to digest DNA-histone complexes (presumably by displacing DNA from histones), whereas fondaparinux does not. These findings are consistent with the KD values of the binding of heparin variants to histones, with fondaparinux having >1000-fold lower affinity for histones compared to the other heparins. Taken together, our data suggests that the ability of heparin to enhance DNase I-mediated digestion of DNA-histone complexes is size-dependent and independent of the pentasaccharide region of heparin. With respect to DNase1L3, we observed that it is able to digest histone-bound DNA, and that all heparins, except fondaparinux, inhibited DNase1L3-mediated digestion of histone-bound DNA. Next, we visualized the degradation of NETs by fluorescence microscopy. DNase I (± heparin variants) completely degraded NETs, presumably by digesting extracellular chromatin at histone-free linker regions, thereby releasing nucleosome units. DNase1L3 also degraded NETs, but not as effectively as DNase I, and was inhibited by all heparins except fondaparinux. Finally, we showed that DNase I levels are decreased and DNase1L3 levels are elevated in septic patients. Taken together, our findings demonstrate that heparin modulates the function of DNases, and that endogenous DNase levels are altered in sepsis pathophysiology. / Thesis / Master of Science (MSc) / Sepsis, a life-threatening condition due to hyperactivation of the immune system in response to infection, results in widespread inflammation and blood clotting. During sepsis, immune cells release sticky strands of DNA that block blood vessels and damage organs. Two different enzymes in the blood (DNase I and DNase1L3) can digest these DNA strands, and may represent a new class of anti-sepsis drugs. Our goal was to determine how heparins, commonly used blood thinners, alter the function of these enzymes. We found that (a) larger-sized heparins improved the activity of DNase I towards DNA-histone complexes and do not require any specific portion of heparin, (b) DNase I is more efficient than DNase1L3 in digesting DNA strands released from immune cells, and (c) levels of DNase I and DNase1L3 are altered in septic patients. Taken together, our studies provide new insights into how these enzymes function.

The core of the dissertation lies in developing two novel systems bioengineering approaches, a synthetic Escherichia coli killer-prey microecology, and a combined infection-inflammation NET-array system, to investigate the role of the mechanochemical complexity of the microenvironment in driving the microbe-microbe and host-microbe interactions, respectively. Herein, the first part of the dissertation includes designing and engineering a synthetic E. coli killer-prey microecological system where we quantified the quorum-sensing mediated interactions between the engineered killer and prey E. coli bacterial strains plated on nutrient-rich media. In this work, we developed the plate assay followed by plasmid sequencing and computational modeling that emphasizes the concept of the constant evolution of species or acquired resistance in the prey E. coli, in the vicinity of the killer strain. We designed the microecological system such that the killer cells (dotted at the center of the plate) constitutively produce and secrete AHL quorum-sensing molecules into the microenvironment. AHL then diffuses into the prey cells (spread throughout the plate) and upregulates the expression of a protein that lyses the prey. Through time-lapse imaging on petri plates automated using a scanner, we recorded the "kill wave" that originates outside the killer colony and travels outward as the prey dies. We found that the prey population density surrounding the killer decreased in comparison to other locations on the plate far from the killer. However, some of the prey colonies evolve to be resistant to the effects of AHL secreted by the killer. These prey colonies resistant to the killer were then selected and confirmed by plasmid sequencing. Using this empirical data, we developed the first ecological model emphasizing the concept of the constant evolution of species, where the survival of the prey species is dependent on the location (distance from the killer) or the evolution of resistance. The importance of this work lies in the context of the evolution of antibiotic-resistant bacterial strains and in understanding the communication between the microbial consortia, such as in the gut microbiome. Further, the second part of the dissertation includes quantifying the interactions between immune cells (primary healthy human neutrophils) and motile Pseudomonas aeruginosa bacteria in an inflammation-rich microenvironment. Neutrophils, being the first responding immune cells to infection, defend by deploying various defense mechanisms either by phagocytosing and killing the pathogen intracellularly or through a suicidal mechanism of releasing their DNA to the extracellular space in the form of Neutrophil Extracellular Traps (NETs) to trap the invading pathogens. Although the release of NETs is originally considered a protective mechanism, it is shown to increase the inflammation levels in the host if unchecked, ultimately resulting in end-organ damage (especially lung and kidney damage), as with the severe cases of sepsis and COVID-19. In our work, we developed a combined infection-inflammation NET-array system integrated with a live imaging assay to quantify the spatiotemporal dynamics of NET release in response to P. aeruginosa infection in an inflammatory milieu at a single-cell resolution. Importantly, we found increased NET release to P. aeruginosa PAO1 when challenged with inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), but not leukotriene B4 (LTB4), compared to the infection alone. Our device platform is unique in that the nanoliter well-assisted individual neutrophil trapping enables us to quantify NET release with single-cell precision. Besides, incorporating confined side loops in the device helped us study the role of mechanical confinement on NET release, showing reduced NET release from neutrophils confined in the side loops compared to the relatively wider chambers of our microsystem. In summary, our work emphasizes the importance of studying the heterogeneity of NET release in host defense and inflammation. In the future, our system can be used for screening novel neutrophil-based immunotherapies and serve as a valuable research tool in precision medicine. / Doctor of Philosophy / The microenvironment plays a vital role in shaping the interactions within microbes and between the host and the microbes. Microbes use quorum-sensing-based chemical signaling to adapt to the environmental stresses in a microecology (be it a soil microecology or the gut microbiome). They communicate with each other with the help of these chemicals to regulate their population density (to mutual benefit in the case of a biofilm formation or to compete for resources in the case of a predator-prey model). In the first part of the dissertation, we utilize this quorum-sensing approach to study the spatiotemporal dynamics of the interactions between two engineered killer and prey Escherichia coli bacterial strains on a nutrient-rich agar plate in real-time. We designed the microecological system such that the killer cells (dotted at the center of the plate) constitutively produce and secrete AHL quorum-sensing molecules into the microenvironment. AHL then diffuses into the prey cells (spread throughout the plate) and upregulates the expression of a protein that lyses the prey. We found that the prey population density surrounding the killer decreased in comparison to other locations on the plate far from the killer. Further, through sequencing, we found that some of the prey colonies acquired resistance to the effects of AHL secreted by the killer. We then developed a computational model that recapitulates our experimental results, emphasizing the concept of the constant evolution of species or acquired resistance. The importance of this work lies in using experimental and computational approaches to better understand the evolution of multidrug-resistant (MDR) bacterial strains. Next, we investigated the interactions between primary human neutrophils (first responding immune cell type to infection) and motile Pseudomonas aeruginosa bacteria in the second part of the dissertation, explicitly focusing on quantifying neutrophil extracellular traps (NETs) release. With increasing concerns regarding the role of the dysregulated NET release in exaggerated inflammatory responses in the host, it is imperative to quantify NET release precisely at a single-cell level in a controlled microenvironment. To this end, we engineered a combined infection-inflammation NET-array device with 1024 nanoliter wells per device and achieved single-cell level trapping of neutrophils in these wells. Our device platform is unique in that the individual wells of the device have constricted side loops, which helps us better understand the role of mechanical confinement on NET release from an engineering standpoint. We then used the NET-array system to quantify the spatiotemporal dynamics of NET release to P. aeruginosa in an inflammatory mediator-rich microenvironment. Importantly, we found heightened NET release to Pseudomonas aeruginosa PAO1 when challenged with inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), but not leukotriene B4 (LTB4), compared to the infection alone. We also demonstrated reduced NET release from neutrophils confined in the side loops compared to the relatively wider chambers of our combined infection-inflammation microsystem. Especially with the increasing complexity of the intercellular cues at the site of infection, by integrating our microfluidic method with the conventional reductionist approaches, we can better solve the intricate puzzles of the immune cell decision-making processes at a single-cell level. Our study highlights the importance of fine-tuning NET release in controlling pathological neutrophil-driven inflammation.

Prolonged strenuous exercise affects the circulating numbers and functions of immune cells. These effects are thought to be largely mediated by the actions of elevated circulating stress hormones and alterations in regulatory cytokines. Although the effects of a single acute bout of exercise on immune system function are quite well established, it is still not clear how time of day and repeated bouts of prolonged exercise on the same day influence immune function. It is of particular interest to understand the effects of nutritional supplementation on immunoendocrine responses. Therefore, the aims of the studies described in this thesis were to determine the effects of two bouts of prolonged cycling and carbohydrate supplementation on immunoendocrine responses. The saliva collection study showed that the use of a swab for collecting saliva is not an ideal method because it affects the results of saliva composition (Chapter 4). The comparison of the effects of exercise at different times of day on immunoendocrine responses showed that a single bout of prolonged exercise performed in the afternoon induces a larger perturbation in the redistribution of leukocytes into the circulation than an identical bout of morning exercise, which maybe due to higher hypothalamic-pituitaryadrenal (HP A) activation and. circadian rhythms. However, in terms of oral mucosal immunity, performing prolonged cycling at different times of day does not differently affect the salivary responses. The second compared with the first of two bouts of prolonged exercise on the same day induces a greater HP A activation, a larger leukocyte trafficking into the circulation, a decreased neutrophil degranulation response to lipopolysaccharide (LPS) on per cell basis and a lower saliva flow rate, but does not increase plasma interleukin-6 (IL-6), or change saliva immunoglobulin A (slgA) secretion rate (Chapter 5). Furthermore, carbohydrate (CHO) ingestion during any period of two bouts of prolonged exercise shows limited beneficial effect in blunting these higher responses in the second exercise bout compared with the first identical exercise bout on the same day (Chapter 6, 7 and 8). The determination of the effects of CHO ingestion on exercise-induced immunoendocrine responses showed that when two bouts of exercise are performed on the same day, the greater benefit in terms of circulating immunoendocrine responses is obtained by feeding CHO at the earliest opportunity (Chapter 6, 7 and 8). A 3-h interval is insufficient for recovery of leukocyte mobilisation and neutrophil function from the impact of previous exercise whether subjects consumed placebo or CHO during exercise or recovery (Chapter 5, 6, 7 and 8). However, an 18-h interval is sufficient for full recovery of all immunoendocrine variables that were measured in this thesis from the impact of two bouts of prolonged exercise (Chapter 8).

Cancer immunotherapy has recently made remarkable clinical progress. Adoptive transfer of T-cells engineered with a chimeric antigen receptor (CAR) against CD19 has been successful in treatment of B-cell leukemia. Patient’s T-cells are isolated, activated, transduced with a vector encoding the CAR molecule and then expanded before being transferred back to the patient. However some obstacles restrict its success in solid tumors. This thesis explores different aspects to improve CAR T-cells therapy of cancer. Ex vivo expanded T-cells are usually sensitive to the harsh tumor microenvironment after reinfusion. We developed a novel expansion method for T-cells, named AEP, by using irradiated and preactivated allo-sensitized allogeneic lymphocytes (ASALs) and allogeneic mature dendritic cells (DCs). AEP-expanded T-cells exhibited better survival and cytotoxic efficacy under oxidative and immunosuppressive stress, compared to T-cells expanded with established procedures. Integrating retro/lentivirus (RV/LV) used for CAR expressions randomly integrate in the T-cell genome and has the potential risk of causing insertional mutagenesis. We developed a non-integrating lentiviral (NILV) vector containing a scaffold matrix attachment region (S/MAR) element (NILV-S/MAR) for T-cells transduction. NILV-S/MAR-engineered CAR T-cells display similar cytotoxicity to LV-engineered CAR T-cells with undetectable level of insertional event, which makes them safer than CAR T-cells used in the clinic today. CD19-CAR T-cells have so far been successful for B-cell leukemia but less successful for B-cell lymphomas, which present semi-solid structure with an immunosuppressive microenvironment. We have developed CAR T-cells armed with H. pylorineutrophil-activating protein (HP-NAP). HP-NAP is a major virulence factor and plays important role in T-helper type 1 (Th1) polarizing. NAP-CAR T-cells showed the ability to mature DCs, attract innate immune cells and increase secretion of Th1 cytokines and chemokines, which presumably leads to better CAR T-cell therapy for B-cell lymphoma. Allogeneic-DCs (alloDCs) were used to further alter tumor microenvironment. The premise relies on initiation of an allo-reactive immune response for cytokine and chemokines secretion, as well as stimulation of T-cell response by bringing in tumor-associated antigen. We demonstrated that alloDCs promote migration and activation of immune cells and prolong the survival of tumor-bearing mice by attracting T-cells to tumors and reverse the immune suppressive tumor microenvironment.

Estudos anteriores demonstraram que o veneno de Crotalus durissus terrificus (VCdt) apresenta ação antiinflamatória prolongada, bem como inibe o espraiamento e a atividade fagocítica de macrófagos peritoneais, sendo a crotoxina (CTX), o principal componente do VCdt, a responsável por esses efeitos. Em relação aos neutrófilos, demonstrou-se que o VCdt inibe, in vitro e in vivo, a fagocitose por essas células, porém o componente do VCdt responsável por esse efeito não foi identificado. Dessa forma, o objetivo desse estudo foi identificar o componente responsável pelo efeito inibitório do VCdt sobre a fagocitose por neutrófilos, bem como investigar os possíveis mecanismos envolvidos nessa ação. Além disso, foi também objetivo desse estudo investigar o efeito do VCdt e da CTX sobre a atividade microbicida e a produção de espécies reativas do oxigênio por essas células. Inicialmente, foi avaliado o efeito in vitro dos três picos do VCdt, obtidos durante a purificação da CTX (pico I; pico II, que corresponde a CTX, e pico III), sobre a atividade fagocítica de neutrófilos. A incubação dos neutrófilos com a CTX ou com os picos I ou III, em diferentes concentrações (0,02; 0,04; 0,08; 0,16 ou 0,32 ug/mL), mostrou que somente o pico II inibiu essa atividade, demonstrando que a CTX é o componente do VCdt responsável pelo seu efeito inibitório sobre a fagocitose por neutrófilos. Uma vez realizada essa identificação, foi investigado o efeito in vivo da CTX sobre essa função. O tratamento dos animais com a CTX (0,1 mg/kg), 2 horas, 1, 4 ou 14 dias antes ou 1 hora após a administração de carragenina inibiu a fagocitose por neutrófilos, o que demonstra que esta toxina, além do efeito direto, apresenta efeito sistêmico sobre a atividade fagocítica dessas células. Esses resultados mostraram também que a CTX apresenta efeito inibitório prolongado sobre a atividade fagocítica de neutrófilos. Ainda, com o objetivo de elucidar os possíveis mecanismos envolvidos nesse efeito inibitório foram realizados ensaios imunocitoquímicos para avaliar a reorganização do citoesqueleto. A incubação dos neutrófilos com o VCdt (0,5 ug/mL) ou com a CTX (0,08 ug/mL), bem como o tratamento dos animais com o VCdt (0,18 mg/kg) ou a CTX (0,1 mg/kg), 2 horas antes da administração de carragenina, inibiram a fosforilação de resíduos de tirosina e a polimerização da actina. Em relação ao efeito do VCdt e da CTX sobre outra função dos neutrófilos, foi investigado, em ensaios in vitro e in vivo, a atividade microbicida e a produção de espécies reativas do oxigênio por essas células. A incubação dos neutrófilos com o VCdt (0,125; 0,25; 0,5; 1,0 ou 2,0 ug/mL) ou a CTX (0,02; 0,04; 0,08; 0,16 ou 0,32 ug/mL), bem como o tratamento dos animais com o VCdt (0,18 mg/kg) ou a CTX (0,1 mg/kg), 2 horas antes da administração de carragenina, não alteraram a atividade microbicida e a produção de ânion superóxido, peróxido de hidrogênio e ácido hipocloroso. Em conclusão, a CTX é o componente do VCdt responsável por inibir a fagocitose por neutrófilos e um dos mecanismos envolvidos neste efeito é a inibição da fosforilação de proteínas sinalizadoras e a conseqüente polimerização de actina, importante evento para o início da formação do fagossoma e a completa internalização da partícula. Por outro lado, o VCdt e a CTX não alteram a atividade microbicida e a produção de espécies reativas do oxigênio por neutrófilos. Dessa forma, considerando-se o papel fundamental dessas células na inflamação, este estudo amplia os conhecimentos das ações moduladoras da CTX sobre a resposta inflamatória e, ainda, contribui para a elucidação dos mecanismos envolvidos nestas ações, particularmente, a inibição do processo de fagocitose por neutrófilos. / Previous studies showed that Crotalus durissus terrificus snake venom (CdtV) has long-lasting anti-inflammatory properties and inhibits the spreading and the phagocytic activity of peritoneal macrophages. Crotoxin (CTX), the main component of CdtV, is responsible for these effects. In addition, CdtV inhibits, in vitro and in vivo, the phagocytic activity of neutrophils, but the component of the venom responsible for this effect was not identified. In this way, the aim of this study was to investigate the CdtV component responsible for the inhibitory effect on phagocytosis by neutrophils, as well as to investigate possible mechanisms involved on this effect. Besides, the aim of this study was also to investigate the effect of CdtV and CTX on the microbicidal activity and the production of reactive oxygen species by neutrophils. Initialy, it was avaliated the in vitro effect of the three peaks of CdtV, obtained during CTX purification (peak I, peak II that corresponds to CTX and peak III), on phagocytosis by neutrophils. The incubation of the cells with CTX, peak I or peak III, at different concentrations (0.02, 0.04, 0.08, 0.16 or 0.32 ug/mL), showed that just peak II inhibited this activity, so CTX is the CdtV component responsible for the inhibitory effect on phagocytosis by neutrophils. Once realized this identification, it was investigated the in vivo effect of CTX on the same neutrophil function. Treating animals with CTX (0.1 mg/kg), 2 hours, 1, 4 or 14 days before or 1 hour after the administration of carrageenan inhibited the phagocytic activity of neutrophils, which demonstrates that this toxin, in addition to the direct effect, has systemic effect on phagocytosis by neutrophils. These results also show that CTX has a long-lasting inhibitory effect on the phagocytic activity of these cells. Further, to elucidate possible mechanisms involved on this inhibitoty effect, immunocytochemical assays was realized to evaluate the reorganization of the cytoskeleton. The incubation of the neutrophils with CdtV (0.5 ug/mL) or CTX (0.08 ug/mL), as well as the treatment of the animals with CdtV (0.18 mg/kg) or CTX (0.1 mg/kg), 2 hours before the carrageenan injection, inhibited the phosphorilation of tyrosine residues and actin polymerization. Regarding the effect of CdtV and CTX in other neutrophil function, it was investigated, in vitro and in vivo, the microbicidal activity and the production of reactive oxygen species by neutrophils. The incubation of the cells with CdtV (0.125, 0.25, 0.5, 1.0 or 2.0 ug/mL) or CTX (0.02, 0.04, 0.08, 0.16 or 0.32 ug/mL), as well as the treatment of the animals with CdtV (0.18 mg/kg) or CTX (0.1 mg/kg), 2 hours before the carragennan injection, did not alter the microbicidal activity or the production of superoxide, hydrogen peroxide and hypochlorous acid. In conclusion, CTX is the CdtV component responsible for the inhibitory effect on phagocytosis by neutrophils and a mechanism involved on this effect is the inhibition of phosphorilation of signaling proteins and the consequent actin polymerization, an important event for the phagosome formation and the complete internalization of the particle. On the other hand, CdtV and CTX did not alter the microbicidal activity or the production of reactive oxygen species. Thus, considering the essential role of these cells in inflammation, this study extends the knowledge of the actions of CTX on modulating the inflammatory response and also contributes to the elucidation of the mechanisms involved in these actions, particularly the inhibition of phagocytosis by neutrophils.

Sepse é a resposta inflamatória sistêmica do hospedeiro à infecção, que pode ser desencadeada por bactérias, vírus ou fungos. Há aumento da produção de mediadores inflamatórios como citocinas, quimiocinas espécies reativas de oxigênio e do recrutamento de neutrófilos. A administração de solução salina hipertônica 7,5% (SH) acarreta na modulação da resposta inflamatória e hemodinâmica culminando na redução da morbidade e mortalidade em modelos de pancreatite e choque hemorrágico. No presente trabalho, estudamos os efeitos da SH na sepse, induzida por ligadura e perfuração cecal (CLP) em camundongos Balb/C, divididos em 3 grupos: CLP sem nenhum tratamento (CLP); CLP tratado com solução salina isotônica 0,9% (SS) e CLP tratado com SH 7,5% (SH); um quarto grupo foi utilizado como controle, no qual não foi induzido sepse ou administrado tratamento (C); ambos os tratamentos foram aplicados 30 min. após CLP. Lavado peritoneal, intestino e pulmão foram coletados após 6h, 12h e 24h para a análise de citocinas (TNF-, IL-6 e IL-10), produção de oxido nítrico, peroxidação lipídica, infiltração de neutrófilos, moléculas de adesão (ICAM-1 e VCAM-1) e quimiocinas (CXCL-1). O grupo SH mostrou aumento de sobrevida (60%) em comparação aos grupos SS (46,6%) e CLP (33,3%) após 168h. SS apresentou aumento na produção de TNF- (27,3 ± 3,05 pg/ml) em 12h comparado ao grupo CLP (14,07 ± 1,68 pg/ml) e SH (19,66±3,19pg/ml); O efeito da SH na concentração de TNF permanece até 24h (6,2 ± 3,5 pg/ml vs. CLP 73,40± 49,52 pg/ml); a produção de IL-10 em 24h aumentaram nos grupos CLP (CLP - 3,12 ± 0,46 pg/ml) e SS (2,9 ± 0,9 pg/ml) em relação ao grupo SH (0,59 ± 0,34 pg/ml). Em 24h a produção de nitrito mostrou-se reduzida no grupo SH (6,77 ± 0,82 pg/ml) comparado com SS (10,65 ± 1,08 pg/ml), no pulmão. No intestino, a produção de nitrito, em 6h, diminuiu no grupo SH (1,27 ± 0,19 pg/ml) comparado com CLP (2,44 + 0,51 pg/ml). No grupo SH houve redução do infiltrado de neutrófilos no pulmão em 24h, através da redução de moléculas de adesão e concentração de mieloperoxidase, em comparação com CLP (29,4 + 5,7 ng/mg ; 3,02 + 0,41 mU/mg). Nossos resultados indicam que SH modula a resposta inflamatória, além de melhorar a sobrevida de animais submetidos à sepse experimental / Sepsis is a systemic inflammatory response to infection triggered by bacteria, virus and fungi. There is a rise in inflammatory mediators as citokynes, chemokynes, reactive oxygen species and neutrophil recruitment (1). The hypertonic saline solution (SH) has been showed to improve hemodynamic and inflammatory response. We studied the hypertonic solution effects in sepsis through cecal ligation and puncture (CLP) in mice Balb-C, divided in 3 groups: CLP without treatment (CLP); CLP treated with isotonic saline solution 0,9% - 34mg/Kg (SS); CLP treated with hypertonic saline solution 7,5% - 4ml/Kg (SH); and a 4th group indicating the basal values without both CLP and treatment (C); both treatments were administrated 30 min after CLP. The lung, gut and peritoneal fluid were collected after 6h, 12h and 24h to analyze cytokines levels, oxide nitric, lipid peroxidation and neutrophil infiltration. The SH group showed higher survival rats (60%) when compared to SS (46,6%) and CLP (33,3%) after 168h (7 days). TNF- level in the SS group (27,3 ± 3,05 pg/ml) was increased at 12h when compared to CLP (14,07 ± 1,68 pg/ml) and SH (19,66±3,19pg/ml); and at 24h the SH (6,2 ± 3,5 pg/ml) decreased its level when compared to CLP (73,40± 49,52 pg/ml); IL-10 level at 24h was increased in CLP (CLP - 3,12 ± 0,46 pg/ml) and SS (2,9 ± 0,9 pg/ml) in relation to SH (0,59 ± 0,34 pg/ml). In 24h, the quantification of nitrite decreased in SH (6,77 ± 0,82 pg/ml) compared with SS (10,65 ± 1,08 pg/ml) in lung. In intestine, nitrite levels diminished in SH (1,27 ± 0,19 pg/ml) in relation to CLP (2,44 + 0,51 pg/ml) in 6h. SH group reduced the neutrophil infiltration in lung, through adhesion molecule and myeloperoxidase at 24h (ng/mg;1,49 + 0,24 mU/mg) in relation to CLP(29,4 + 5,7 ng/mg ; 3,02 + 0,41 mU/mg). Our results suggest that the volume replacement of both treatments modulate pro and anti-inflammatory mediators of an inflammatory response to infection, but hypertonic solution presented a more effective effect